Fu D - Search Results

1

Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.

Fu D, Zhang B, Wu S, Feng J, Jiang H. Fu D, et al. Front Cell Dev Biol. 2023 Aug 24;11:1207642. doi: 10.3389/fcell.2023.1207642. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37691822 Free PMC article.

2

Identification of prognostic genes in the acute myeloid leukemia microenvironment.

Huang S, Zhang B, Fan W, Zhao Q, Yang L, Xin W, Fu D. Huang S, et al. Among authors: fu d. Aging (Albany NY). 2019 Nov 18;11(22):10557-10580. doi: 10.18632/aging.102477. Epub 2019 Nov 18. Aging (Albany NY). 2019. PMID: 31740623 Free PMC article.

3

Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses.

Zhang B, Yang L, Wang X, Fu D. Zhang B, et al. Among authors: fu d. Gene. 2021 Jan 5;764:145105. doi: 10.1016/j.gene.2020.145105. Epub 2020 Aug 31. Gene. 2021. PMID: 32882333

4

Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma.

Fu D, Zhang B, Yang L, Huang S, Xin W. Fu D, et al. Front Genet. 2020 Aug 28;11:978. doi: 10.3389/fgene.2020.00978. eCollection 2020. Front Genet. 2020. PMID: 33005178 Free PMC article.

5

Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.

Fu D, Zhang B, Wu S, Zhang Y, Xie J, Ning W, Jiang H. Fu D, et al. Front Immunol. 2021 May 31;12:695865. doi: 10.3389/fimmu.2021.695865. eCollection 2021. Front Immunol. 2021. PMID: 34135913 Free PMC article.

6

Identification of survival-related alternative splicing signatures in acute myeloid leukemia.

Zhang B, Yang L, Wang X, Fu D. Zhang B, et al. Among authors: fu d. Biosci Rep. 2021 Jul 30;41(7):BSR20204037. doi: 10.1042/BSR20204037. Biosci Rep. 2021. PMID: 34212178 Free PMC article.

7

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor.

Jiang H, Fu D, Bidgoli A, Paczesny S. Jiang H, et al. Among authors: fu d. Front Immunol. 2021 Oct 5;12:761448. doi: 10.3389/fimmu.2021.761448. eCollection 2021. Front Immunol. 2021. PMID: 34675938 Free PMC article. Review.

8

Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease.

Bidgoli A, DePriest BP, Saatloo MV, Jiang H, Fu D, Paczesny S. Bidgoli A, et al. Among authors: fu d. Transplant Cell Ther. 2022 Oct;28(10):657-666. doi: 10.1016/j.jtct.2022.07.008. Epub 2022 Jul 11. Transplant Cell Ther. 2022. PMID: 35830932 Free PMC article. Review.

9

Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease.

Yuan X, Jiang H, Fu D, Robida A, Rajanayake K, Yuan H, Wen B, Sun D, Watch BT, Chinnaswamy K, Stuckey JA, Paczesny S, Rech JC, Yang CY. Yuan X, et al. Among authors: fu d. Bioorg Med Chem. 2022 Oct 1;71:116942. doi: 10.1016/j.bmc.2022.116942. Epub 2022 Jul 22. Bioorg Med Chem. 2022. PMID: 35930851 Free PMC article.

10

Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature.

Jing L, Du Y, Fu D. Jing L, et al. Among authors: fu d. Front Genet. 2022 Aug 29;13:979575. doi: 10.3389/fgene.2022.979575. eCollection 2022. Front Genet. 2022. PMID: 36105083 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,930 results

Search Page